Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Craig Reynolds, MD
US Oncology Research
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancer Centers of Florida, P.A.
Ocoee, Florida, United States
- Hope Center
Terre Haute, Indiana, United States
- Alliance Hematology Oncology Pa
Westminster, Maryland, United States
- St Joseph Oncology, Inc
Saint Joseph, Missouri, United States
- New York Oncology Hematology, Pc
Albany, New York, United States
- Northwestern Carolina Oncology Hemato
Hickory, North Carolina, United States
- Medical Oncology Associates
Kingston, Pennsylvania, United States
- South Texas Cancer Center-Mcallen
McAllen, Texas, United States
- Texas Oncology Cancer Center-Sugar Land
Sugar Land, Texas, United States
- Cancer Care Northwest-South
Spokane, Washington, United States
- Yakima Valley Mem Hosp/north Star Lodge
Yakima, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2003
- Primary completion
- 30 Sept 2011
- Completion
- 30 Sept 2011
- Last update posted
- 3 Nov 2016
- Registered enrollment
- 184
- Registry id
- NCT00254163
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.